The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Belova L.A.

Ul'ianovskiĭ gosudarstvennyĭ universitet

Mashin V.V.

Kolotik-Kameneva O.Iu.

Belova N.V.

Scuderi A.

University Hospital Santa Lucinda, Sorocaba, Brasil

Antignani P.L.

Vascular Center of «Nuova Villa Claudia», Rome, Italy

The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease

Authors:

Belova L.A., Mashin V.V., Kolotik-Kameneva O.Iu., Belova N.V., Scuderi A., Antignani P.L.

More about the authors

Read: 3384 times


To cite this article:

Belova LA, Mashin VV, Kolotik-Kameneva OIu, Belova NV, Scuderi A, Antignani PL. The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2017;117(7):28‑35. (In Russ.)
https://doi.org/10.17116/jnevro20171177128-35

Recommended articles:
Improving the effe­ctiveness of treatment of patients with post-stroke apha­sia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(10):22-28
Diagnosis of neuroinfections in children. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11-2):51-59
The role of drug Cyto­flavin in the correction of dysautonomia in patients with post-COVID syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):140-146
The possibilities of Mexi­dol in the complex therapy of arte­rial hype­rtension. Russian Journal of Cardiology and Cardiovascular Surgery. 2024;(5):572-580
«Selfish brain» theory: modern concept and practical use. (Literature review). Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(5):66-73
Features of arte­rial blood flow velo­city characteristics in endo­thelial dysfunction. Russian Journal of Preventive Medi­cine. 2024;(12):100-106

References:

  1. Piradov MA, Tanashyan MM, Domashenko MA, Maksimova MYu. Neuroprotection in cerebrovascular diseases: is it the search for life on Mars or a promising trend of treatment? Part 2. Chronic cerebrovascular diseases. Annaly klinicheskoi i eksperimental’noi nevrologii. 2015;3(9):10-16. (In Russ.).
  2. Gnedovskaya ЕV, Kravchenko MA, Prokopovich ME, Andreeva OS, Sergeev DV, Oshchepkova EV, Varakin YuYa, Piradov MA. Prevalence of the risk factors of cerebrovascular disorders in the capital city residents aged 40-59: a clinical and epidemiological study. Annaly klinicheskoi i eksperimental’noi nevrologii. 2016;4(10):111-136. (In Russ.).
  3. Joutel A, Chabriat H. Pathogenesis of white matter changes in cerebral small vessel diseases: beyond vessel-intrinsic mechanisms. Clin Sci (Lond). 2017;131(8):635-651. https://doi.org/10.1042/CS20160380
  4. Mashin VV, Belova LA, Saprygina LV, Kravchenko MA, Varakin YuYа, Gnedovskaya EV, Suslina ZA. Risk Factors for cerebrovascular disease according to the screening of middle-aged population of Ulyanovsk. Annaly klinicheskoi i eksperimental’noi nevrologii. 2014;1(8):4-9. (In Russ.).
  5. Belova LA, Mashin VV, Tararak TYa, Belov VG. The influence of cerebral venous discirculation. Uchenye zapiski UlGU, seriya «klinicheskaya meditsina». 2006;1(11):85-91. (In Russ.).
  6. Gulevskaya TS, Morgunov VA. Ocherki angionevrologii. M.: Izdatel’stvo «Atmosfera». 2005:49-66. (In Russ.).
  7. Dikalov SI, Dikalova AE. Contribution of mitochondrial oxidative stress to hypertension. Curr Opin Nephrol Hypertens. 2016;25(2):73-80. https://doi.org/10.1097/MNH.0000000000000198
  8. Owada T, Yamauchi H, Saitoh SI, Miura S, Machii H, Takeishi Y. Resolution of mitochondrial oxidant stress improves aged-cardiovascular performance. Coron Artery Dis. 2017;28(1):33-43. https://doi.org/10.1097/mca.0000000000000434
  9. Lob HE, Schultz D, Marvar PJ, Davisson RL, Harrison DG. Role of the NADPH oxidases in the subfornical organ in angiotensin II-induced hypertension. Hypertension. 2013;61(2):382-387. https://doi.org/10.1161/hypertensionaha.111.00546
  10. Mattias C, Christopher SW, William JA. Renal Autoregulation in Health and Disease. Physiol Rev. 2015;95(2):405-511. https://doi.org/10.1152/physrev.00042.2012
  11. Montezano AC, Tsiropoulou S, Dulak-Lis M, Harvey A, Camargo Livia De Lucca, Touyz RM. Redox signaling, Nox5 and vascular remodeling in hypertension. Curr Opin Nephrol Hypertens. 2015;24(5):425-433. https://doi.org/ 10.1097/mnh.0000000000000153
  12. Arba F, Mair G, Carpenter T, Sakka E, Sandercock PA, Lindley RI, Inzitari D, Wardlaw JM; IST-3 Trial Collaborators. Cerebral White Matter Hypoperfusion Increases with Small-Vessel Disease Burden. Data From the Third International Stroke Trial. J Stroke Cerebrovasc Dis. 2017; pii:S1052-3057(17)30105-2. https://doi.org/10.1016/j.jstrokecerebrovasdis.2017.03.002
  13. Afanas’ev VV, Beneskriptov IS. Lekarstvennye kombinatsii tsitoflavina s preparatami drugikh farmakologicheskikh grupp (v tablitsakh i skhemakh). SPb.: Taktik-Studio. 2016. (In Russ.).
  14. Zaplutanov VA. Tsitoflavin: sbornik nauchnykh statei. SPb.: Taktik-Studio. 2008. (In Russ.).
  15. Belova LA, Kolotik-Kameneva OYu, Mashin VV, Belova NV, Scuderi A, Antignani PL. The influence of Cytoflavin therapy on the cerebral hemodynamics condition in patients with various stages of hypertensive disease. Terapevticheskii arkhiv. 2016;5:55-61. (In Russ.). https://doi.org/10/17116/terarkh201688555-61
  16. Belova LA, Mashin VV, Kolotik-Kameneva OYu, Belova NV, Byrina AV, Yevstigneyeva AYu, Abramova VV. Cytoflavin effect in patients with hypertensive encephalopathy with constitutional venous insufficiency. Zhurnal nevrologii i psikhiatrii im. SS Korsakova. 2012;112(8):21-26. (In Russ.).
  17. Belova LA, Kolotik-Kameneva OYu, Mashin VV, Abramova VV, Saprygina LV, Burtsev SV. Condition of cerebral venous hemodynamics in patients with hypertonic encephalopathy with constitutional venous insufficiency in the process of neuroprotective therapy. Klinicheskaya fiziologiya krovoobrashcheniya. 2013;3:28-36. (In Russ.).
  18. Belova LA, Kolotik-Kameneva OYu, Mashin VV, Saprygina LV, Mashin EV. Efficacy of the energy-modifier cytoflavin in the treatment of patients with hypertensive encephalopathy. Terapevticheskii arkhiv. 2014;9(86):65-71. (In Russ.).
  19. Belova LA, Mashin VV, Kolotik-Kameneva OYu, Proshin AN. Cytoflavin Effect on Endothelium Function and Cerebral Hemodynamics in Patients with Hypertensive Enceplalopathy. Antibiotiki i khimioterapiya. 2014;7-8(59):30-36. (In Russ.).
  20. Nikitin YuM. Novaya kontseptsiya strukturno-funktsional’nykh urovnei sosudistoi sistemy golovnogo mozga v otsenke ul’trazvukovoi diagnostiki. 13 Mezhdunarodnaya konferentsiya «Angiodop-2006». M. 2006;98-101. (In Russ.).
  21. Lelyuk VG, Lelyuk SE. Tserebrovaskulyarnyi rezerv pri ateroskleroticheskom porazhennii brakhiotsefalnykh arterii. Etyudy sovremennoi ul’trazvukovoi diagnostiki. Vypusk 2. Kiev.: Ukrmed. 2001. (In Russ.).
  22. Raffetto JD. Which dressings reduce inflammation and improve venous leg ulcer healing. Phlebology. 2014;29(1 suppl):157-164. https://doi.org/10.1177/0268355514529225
  23. Van Geemen D, Smeets MWJ, van Stalborch A-MD, Woerdeman LAE, Daemen MJAP, Hordijk PL, Huveneers S. F-actin-anchored focal adhesions distinguish endothelial phenotypes of human arteries and veins. Arterioscler Thromb Vasc Biol. 2014;34(9):2059-2067. https://doi.org/10.1161/atvbaha.114.304180
  24. Adamson RH, Sarai RK, Altangerel A, Clark JF, Weinbaum S, Curry FE. Microvascular permeability to water is independent of shear stress, but dependent on flow direction. Am J Physiol Heart Circ Physiol. 2013;11:1077-1084.
  25. Belova LA, Mashin VV. Venoznaja discirkuljacija pri hronicheskih formah cerеbrovaskuljarnoj patologii. Ul’yanovsk: UlGU. 2014. (In Russ.).
  26. Belova LA. Effective therapy of hypertensive encephalopathy. Sovremennaja medicina. 2016;1(1):17-20. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.